Proquility Private Wealth Partners LLC Reduces Position in HCA Healthcare, Inc. (NYSE:HCA)

Proquility Private Wealth Partners LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 55.5% during the fourth quarter, Holdings Channel.com reports. The firm owned 1,202 shares of the company’s stock after selling 1,497 shares during the period. Proquility Private Wealth Partners LLC’s holdings in HCA Healthcare were worth $361,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Transform Wealth LLC boosted its position in shares of HCA Healthcare by 12.7% in the fourth quarter. Transform Wealth LLC now owns 25,278 shares of the company’s stock worth $7,587,000 after acquiring an additional 2,847 shares during the last quarter. Clear Harbor Asset Management LLC purchased a new position in shares of HCA Healthcare in the 4th quarter worth $320,000. Clarius Group LLC increased its stake in HCA Healthcare by 19.1% during the fourth quarter. Clarius Group LLC now owns 1,540 shares of the company’s stock worth $462,000 after acquiring an additional 247 shares during the last quarter. Arkadios Wealth Advisors lifted its stake in shares of HCA Healthcare by 46.9% in the 4th quarter. Arkadios Wealth Advisors now owns 3,435 shares of the company’s stock valued at $1,031,000 after purchasing an additional 1,096 shares in the last quarter. Finally, Canoe Financial LP raised its holdings in HCA Healthcare by 226,952.9% in the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock valued at $69,513,000 after buying an additional 231,492 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the subject of several recent research reports. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. KeyCorp reduced their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Trading Up 2.6 %

Shares of NYSE HCA opened at $318.47 on Wednesday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a market cap of $80.67 billion, a price-to-earnings ratio of 14.30, a price-to-earnings-growth ratio of 1.06 and a beta of 1.64. HCA Healthcare, Inc. has a 12-month low of $278.68 and a 12-month high of $417.14. The stock’s 50 day simple moving average is $315.74 and its 200 day simple moving average is $353.08.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Insider Transactions at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.